Literature DB >> 17640236

Pagetoid reticulosis with CD30 positivity and cytotoxic/suppressor cells.

Witold K Jacyk1, Wayne Grayson, Jurgen Erich Dinkel, Luis Requena.   

Abstract

Pagetoid reticulosis (PR) is a low-grade primary cutaneous T-cell lymphoma that usually presents as a solitary, slowly enlarging erythematous or hyperkeratotic plaque on the distal areas of the extremities. Histopathologically, it is characterized by a dense, band-like infiltrate of atypical lymphocytes with prominent epidermotropism within a hyperplastic epidermis, and immunophenotypic studies show in most cases, a CD4-positive T-helper phenotype for the neoplastic lymphocytes. We describe an African man with a more than 20-year history of an acral lesion of PR, which was histopathologically characterized by lymphocyte immunophenotype consisting of CD8- and CD30-positive cells. We discuss the differential diagnosis with other primary cutaneous lymphoproliferative disorders showing similar immunophenotype. This case shows that CD30-positive PR should be included as a rare variant within the spectrum of CD30-positive primary cutaneous lymphoproliferative disorders. As in other primary cutaneous CD30-positive lymphoproliferative processes, lesions of CD30-positive PR show an indolent course and a benign biological behavior.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640236     DOI: 10.1111/j.1600-0560.2006.00698.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  2 in total

1.  A case of primary cutaneous anaplastic large cell lymphoma with prominent epidermotropism.

Authors:  Tomomitsu Miyagaki; Makoto Sugaya; Akie Miyamoto; Kunihiko Tamaki; Satoshi Ota; Shinichi Sato
Journal:  Int J Hematol       Date:  2012-03-27       Impact factor: 2.490

2.  CD8+ Pagetoid Reticulosis Presenting as a Solitary Foot Plaque in a Young Woman.

Authors:  Stephanie J Martin; Philip R Cohen; Jeong Hee Cho-Vega; Jaime A Tschen
Journal:  J Clin Aesthet Dermatol       Date:  2010-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.